Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd > Why does Alamos want Aurizon?

<< Previous

Bullboard Posts

Next >>

Comment by MrMonkon Jan 15, 2013 3:01pm

144 Views

Post# 20841423

RE: RE: Why does Alamos want Aurizon?

With all due respect, there is no such thing as a sure thing. What you say about further investment or a buyout is likely, however saying the words "sure thing" causes you to lose credibility.

Another statement that calls credibility into question is the suggestion that Alamos purchased Aurizon because of Niogold. They didn't spend $780 million to purchase a 50% stake in Marban. I am confident that Niogold was a very nice secondary reason for the acquisition, however there's no way it was the primary reason (or even one of them).

Let's keep things in perspective here...

MM

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario